165 related articles for article (PubMed ID: 35584242)
21. Availability of tobacco cessation services in substance use disorder treatment programs: Impact of state tobacco control policy.
Abraham AJ; Bagwell-Adams G; Jayawardhana J
Addict Behav; 2017 Aug; 71():12-17. PubMed ID: 28231493
[TBL] [Abstract][Full Text] [Related]
22. State Medicaid coverage for tobacco-dependence treatments - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(43):1199-204. PubMed ID: 19893479
[TBL] [Abstract][Full Text] [Related]
23. Making the case for medicaid funding of smoking cessation treatment programs: an application to state-level health care savings.
McCallum DM; Fosson GH; Pisu M
J Health Care Poor Underserved; 2014 Nov; 25(4):1922-40. PubMed ID: 25418250
[TBL] [Abstract][Full Text] [Related]
24. Appalachian disparities in tobacco cessation treatment utilization in Medicaid.
Goodin A; Talbert J; Freeman PR; Hahn EJ; Fallin-Bennett A
Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):5. PubMed ID: 31959212
[TBL] [Abstract][Full Text] [Related]
25. Medicaid coverage of tobacco-dependence treatment for pregnant women: impact of the Affordable Care Act.
McMenamin SB; Halpin HA; Ganiats TG
Am J Prev Med; 2012 Oct; 43(4):e27-9. PubMed ID: 22992368
[TBL] [Abstract][Full Text] [Related]
26. Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
Jarlenski M; Hyon Baik S; Zhang Y
Am J Prev Med; 2016 Sep; 51(3):301-8. PubMed ID: 27036506
[TBL] [Abstract][Full Text] [Related]
27. Knowledge of Medicaid coverage and effectiveness of smoking treatments.
McMenamin SB; Halpin HA; Bellows NM
Am J Prev Med; 2006 Nov; 31(5):369-74. PubMed ID: 17046407
[TBL] [Abstract][Full Text] [Related]
28. Tobacco control policies and smoking cessation treatment utilization: A moderated mediation analysis.
Thrul J; Riehm KE; Cohen JE; Alexander GC; Vernick JS; Mojtabai R
PLoS One; 2021; 16(8):e0241512. PubMed ID: 34460821
[TBL] [Abstract][Full Text] [Related]
29. Implementing parity for mental health and substance use treatment in Medicaid.
Burns ME; Dague L; Saloner B; Voskuil K; Kim NH; Serna Borrero N; Look K
Health Serv Res; 2020 Aug; 55(4):604-614. PubMed ID: 32578233
[TBL] [Abstract][Full Text] [Related]
30. Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.
Hemmy Asamsama O; Miller SC; Silvestri MM; Bonanno C; Krondilou K
J Subst Abuse Treat; 2019 Dec; 107():44-49. PubMed ID: 31757264
[TBL] [Abstract][Full Text] [Related]
31. A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.
Land T; Rigotti NA; Levy DE; Paskowsky M; Warner D; Kwass JA; Wetherell L; Keithly L
PLoS Med; 2010 Dec; 7(12):e1000375. PubMed ID: 21170313
[TBL] [Abstract][Full Text] [Related]
32. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
[TBL] [Abstract][Full Text] [Related]
33. State Medicaid Expansion Tobacco Cessation Coverage and Number of Adult Smokers Enrolled in Expansion Coverage - United States, 2016.
DiGiulio A; Haddix M; Jump Z; Babb S; Schecter A; Williams KS; Asman K; Armour BS
MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(48):1364-1369. PubMed ID: 27932786
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the Patient Protection and Affordable Care Act's Increase in Fees for Primary Care and Access to Care for Dual-Eligible Beneficiaries.
Fung V; Price M; Hull P; Cook BL; Hsu J; Newhouse JP
JAMA Netw Open; 2021 Jan; 4(1):e2033424. PubMed ID: 33475756
[TBL] [Abstract][Full Text] [Related]
35. Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders.
Snider JT; Duncan ME; Gore MR; Seabury S; Silverstein AR; Tebeka MG; Goldman DP
JAMA Netw Open; 2019 Apr; 2(4):e193056. PubMed ID: 31026034
[TBL] [Abstract][Full Text] [Related]
36. Racial/Ethnic Differences in the Response to Incentives for Quitline Engagement.
Vijayaraghavan M; Dove MS; Stewart SL; Cummins SE; Schillinger D; Kohatsu ND; Tong EK
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S186-S195. PubMed ID: 30454673
[TBL] [Abstract][Full Text] [Related]
37. State Medicaid coverage for tobacco-dependence treatments--United States, 1994-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 May; 52(21):496-500. PubMed ID: 12809111
[TBL] [Abstract][Full Text] [Related]
38. Perceived barriers to quitting cigarettes among hospitalized smokers with substance use disorders: A mixed methods study.
Kathuria H; Seibert RG; Cobb V; Herbst N; Weinstein ZM; Gowarty M; Jhunjhunwala R; Helm ED; Wiener RS
Addict Behav; 2019 Aug; 95():41-48. PubMed ID: 30836208
[TBL] [Abstract][Full Text] [Related]
39. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
